Predicting Visual Acuity by Using Machine Learning in Patients Treated for Neovascular Age-Related Macular Degeneration.

Journal: Ophthalmology
PMID:

Abstract

PURPOSE: To predict, by using machine learning, visual acuity (VA) at 3 and 12 months in patients with neovascular age-related macular degeneration (AMD) after initial upload of 3 anti-vascular endothelial growth factor (VEGF) injections.

Authors

  • Markus Rohm
    Department of Ophthalmology, Ludwig-Maximilians-University Munich, Germany; Department of Computer Science, Ludwig-Maximilians-University Munich, Germany.
  • Volker Tresp
    Department of Computer Science, Ludwig-Maximilians-University Munich, Germany.
  • Michael Müller
    Department of Ophthalmology, Ludwig-Maximilians-University Munich, Germany.
  • Christoph Kern
    Department of Ophthalmology, Ludwig-Maximilians-University Munich, Germany.
  • Ilja Manakov
    ImFusion GmbH, Munich , Germany.
  • Maximilian Weiss
    Department of Ophthalmology, Ludwig-Maximilians-University Munich, Germany.
  • Dawn A Sim
    National Institutes of Health Research Biomedical Research Centre Biomedical Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Siegfried Priglinger
    Department of Ophthalmology, Ludwig-Maximilians-University Munich, Germany.
  • Pearse A Keane
    National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Karsten Kortuem
    Department of Ophthalmology, Ludwig-Maximilians-University Munich, Germany; Moorfields Eye Hospital, London, United Kingdom. Electronic address: karsten.kortuem@med.uni-muenchen.de.